van Elsas Andrea 4/A
4/A · ADURO BIOTECH, INC. · Filed Dec 15, 2017
Insider Transaction Report
Form 4/AAmended
van Elsas Andrea
Chief Scientific Officer
Transactions
- Award
Common Stock
2017-09-12+27,975→ 207,503 total - Sale
Common Stock
2017-09-13$10.99/sh−4,922$54,072→ 202,581 total
Footnotes (3)
- [F1]This amendment is being filed to correct the ministerial error in the number of shares granted in restricted stock units to the Reporting Person.
- [F2]Represents grant of restricted stock units payable in common stock that vest in four equal annual installments from the grant date of September 12, 2017.
- [F3]The shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.